# Tesarakt

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tesarakt

- Industry: Biotechnology
- Headquarters: Palo Alto, US
- Website: www.tesarakt.com
- Latest round: Seed (Apr 15, 2022)
- Investors on record: 1

## About

Tesarakt is a healthcare technology company that utilizes artificial intelligence and big data to enhance healthcare systems, focusing on developing analytics and machine learning platforms for improved patient outcomes.Founded in 2022 in Palo Alto, US, Tesarakt specializes in healthcare technology solutions that leverage AI and big data. The company was established by Jia Guo, who has a background in technology and innovation. Tesarakt has completed a single deal, raising seed funding in April 2022 from SOSV.Tesarakt Inc. specializes in leveraging artificial intelligence and big data technologies to enhance healthcare systems. The company focuses on developing advanced analytics and machine learning platforms that enable healthcare providers to improve patient outcomes through better data insights. Their core product offerings include solutions designed to analyze vast amounts of healthcare data, facilitating predictive analytics, personalized medicine, and operational efficiency. These products target healthcare institutions such as hospitals, research facilities, and healthcare technology companies across North America and Europe, aiming to streamline processes and improve decision-making in clinical settings. As a Columbia University spin-off, Tesarakt is positioned at the intersection of research and practical application, enhancing their credibility in the healthcare technology sector.Tesarakt's revenue model is structured around B2B transactions, primarily through subscription-based services and partnerships with healthcare organizations. The company engages with clients by providing access to its AI-driven platforms on a subscription basis, enabling continuous use and updates for a set fee. This model includes tiered pricing plans that cater to various organizational sizes and needs, allowing for scalable solutions tailored to the specific requirements of different healthcare providers. Collaborations with healthcare networks and technology partners further enhance their market reach, facilitating a steady revenue stream from integrated service offerings.Tesarakt is focused on developing new AI-driven products aimed at improving healthcare analytics, with potential launches expected in the next 12-18 months. The company plans to expand its services into European markets and seek partnerships with key healthcare institutions by the end of 2023. The recent seed funding raised in April 2022 will be utilized to support product development and market expansion efforts.

## Funding rounds

- Seed, Apr 15, 2022 — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed